0

Global Womens Health Market 2016-2020

  • Published: Apr 2016
  • Pages: 65
  • SKU: IRTNTR9224
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

This market research study presents a detailed segmentation of the global women’s health market by application (post-menopausal osteoporosis, infertility, endometriosis, contraceptives, menopause, and polycystic ovary syndrome) and by geography (Americas, APAC, Europe, and MEA). The key vendors in the market are Allergan, Bayer HealthCare, Merck, Pfizer, and Teva Pharmaceuticals.

Outlook of the women’s health market

Technavio’s market research analysts have predicted the global women’s health market to grow at a CAGR of more than 3% over the forecast period. With many countries improving the healthcare facilities, the market for women’s health will have a positive outlook in the coming years. Many countries have substantially increased their healthcare budgets as a part of their social security measure. For instance, the US government spend 17% of their GDP on the healthcare sector in 2014. With such increases in the budgets by various countries, the women’s health market is expected to show positive growth until the end of 2020.

In this industry research report, the analysts have estimated factors such as the growing awareness of birth control methods will spur the growth of this market in the forecast period. Contraception and fertility control are supported by the governments of developing nations such as India and China to curb the growing population. However, in western countries women have stopped using contraceptive pill due to their side effects and are increasingly using IUDs and implants. Therefore, the increasing awareness about alternative growth methods will aid in the growth of this market until the end of 2020.

Segmentation by application and analysis of women’s health market

  • Postmenopausal osteoporosis
  • Infertility
  • Endometriosis
  • Contraceptives
  • Menopause
  • Polycystic ovary syndrome

During 2015, the postmenopausal osteoporosis segment dominated the market and accounted for more than 37% of the market share. Factors such as the rising number of older people worldwide. Women above 50 are likely to be affected with postmenopausal symptoms due to various hormonal changes. According to the International Osteoporosis Foundation, it is expected that close to 200 million women will be affected by postmenopausal osteoporosis globally, thereby spurring the growth of this market segment over the forecast period.

Geographical segmentation and analysis of women’s health market

  • Americas
  • APAC
  • Europe
  • MEA

In 2015, the global women’s heath market was led by the Americas accounting for close to 40% of the market share. The region is exhibiting consistent growth because of the increasing population of older women affected by diseases such as breast cancer, endometriosis, and postmenopausal osteoporosis. Moreover, the presence of several labs and research facilities in the region will also drive this market’s growth in the Americas.

Competitive landscape and key vendors

The global women’s health market is highly fragmented and is characterized by the presence of several international and regional vendors. The vendors in this market compete in terms of price, quality, product differentiation, distribution, and promotion to gain maximum market prominence during the forecast period. The competitive environment is likely to intensify with an increase in product or service extensions, product innovations, and M&A.

Key vendors in this market are -

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals

Other prominent vendors in the market include Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Mayer Laboratories, Medicines 360, Neurocrine Biosciences, Novartis, Novo Nordisk, Pantarhei Bioscience, and Sanofi.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global women’s health market?
  • What are the key market trends impacting the growth of the global women’s health market?
  • What are the challenges to market growth for global women’s health market?
  • Who are the key vendors in the global women’s health market?
  • What are the market opportunities and threats faced by the vendors in the global women’s health market?
  • Trending factors influencing the market shares of the Americas, APAC, Europe, and MEA.
  • What are the key outcomes of the five forces analysis of the global women’s health market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

Read More Read Less

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by application

  • Market overview
  • Global postmenopausal osteoporosis market
  • Global contraceptives market
  • Global infertility market
  • Global menopause market
  • Global endometriosis market
  • Global polycystic ovary syndrome market

PART 07: Geographical segmentation

  • Market overview
  • Women's health market in Americas
  • Women's health market in Europe
  • Women's health market in APAC
  • Women's health market in MEA

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Consumer Staples
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>